<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04716439</url>
  </required_header>
  <id_info>
    <org_study_id>E-20-4965</org_study_id>
    <nct_id>NCT04716439</nct_id>
  </id_info>
  <brief_title>Effect of TIVA With Magnesium Sulfate on IONM in Patients Undergoing Spine Surgery</brief_title>
  <official_title>Effect of Total Intravenous Anesthesia (TIVA) With Magnesium Sulfate on Intra-Operative Neuromonitoring (IONM) in Patients Undergoing Spine Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Khalid University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Khalid University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anesthesia for neurosurgery requires balancing deep and effective anesthesia as well as&#xD;
      postoperative analgesia versus the risks of delayed recovery and postoperative respiratory&#xD;
      depression. This randomized placebo-controlled, double-blind study was designed to evaluate&#xD;
      the effect of magnesium sulfate on the total anesthetic and analgesic consumption using the&#xD;
      clinical parameters in addition to the effect on IONM reading.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:&#xD;
&#xD;
        1. Decrease anesthetic consumption&#xD;
&#xD;
        2. Decrease use of muscle relaxants&#xD;
&#xD;
        3. Decrease analgesic consumption&#xD;
&#xD;
        4. Excellent recovery&#xD;
&#xD;
      Patients &amp; Methods:&#xD;
&#xD;
        -  2 groups (total 50) Randomized Controlled Double Blind (RCDB) Study&#xD;
&#xD;
        -  Propofol + remifentanil + saline (Control = C group)&#xD;
&#xD;
        -  Propofol + remifentanil + Mgso4 (Magnesium = M group)&#xD;
&#xD;
        -  Adult Spine decompression and fixation After getting the Institutional Review Board&#xD;
           (IRB) approval, This randomized controlled double blind study includes 2 groups of&#xD;
           patients (each group 25) will be enrolled in the study. All patients undergo spine&#xD;
           decompression and fixation surgery&#xD;
&#xD;
      Induction:&#xD;
&#xD;
      All patients in the study will receive iv fentanyl 2 mic/kg + propofol 2mg/kg and&#xD;
      endotracheal intubation will be facilitated with rocuronium 0.60 mg/ kg. Then anesthesia will&#xD;
      be maintained using total intravenous anesthesia with propofol (6-9 mg/kg/hr) + remifentanil&#xD;
      (0.03-0.05 mic / kg/ min) Group 1 (C group) : Receive 10 mg/kg /hr 0.9% Normal Saline Group 2&#xD;
      (M group) : Receive 10 mg/kg/hr Magnesium Sulfate&#xD;
&#xD;
      Monitoring:&#xD;
&#xD;
        1. IONM&#xD;
&#xD;
        2. train-of-four (TOF)&#xD;
&#xD;
        3. bispectral index (BIS)&#xD;
&#xD;
      Measurements:&#xD;
&#xD;
        1. IO Anesthetic Consumption&#xD;
&#xD;
        2. IO Hemodynamics&#xD;
&#xD;
        3. somatosensory evoked potential (SSEP), motor evoked potential (MEP), TOF, BIS Readings&#xD;
&#xD;
        4. PO visual analogue scale (VAS) (24hours)&#xD;
&#xD;
        5. PO Morphine Consumption (24hours)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>8 Months</target_duration>
  <primary_outcome>
    <measure>IONM Reading</measure>
    <time_frame>1- baseline 2-during surgery 3-immediately after surgery</time_frame>
    <description>Reading the effect on the intraoperative neuromonitoring either motor or sensory evoked potential</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hours</time_frame>
    <description>Systolic, Diastolic and Mean (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>1- baseline 2-during surgery 3-immediately after surgery 4- every one hour postoperative till 24 hours</time_frame>
    <description>beats/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine Consumption</measure>
    <time_frame>Over 24 hours postoperative</time_frame>
    <description>Total morphine consumed over 24 hours in mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>Over 24 hours postoperative</time_frame>
    <description>11 Visual Analogue Scale (VAS) with 10 is the worst and 0 is the least</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Spine Surgery</condition>
  <arm_group>
    <arm_group_label>magnesium sulfate effect on IONM reading in spine surgery</arm_group_label>
    <description>one group receives magnesium other do not</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spine Surgery</intervention_name>
    <description>spine decompression and fixation</description>
    <arm_group_label>magnesium sulfate effect on IONM reading in spine surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult ASA 1OR 2&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult Patients Undergoing Spine Surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Renal Impairment&#xD;
&#xD;
          2. Liver Cell failure&#xD;
&#xD;
          3. Heart Block&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ESSAM M MANAA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor and Consultant, Anesthesia Department, Faculty of Medicine, KKUH, KSU, Riyadh, Saudi Arabia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ESSAM M MANAA, MD</last_name>
    <phone>+966509870124</phone>
    <email>e_manaa@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Anesthesia Department, Faculty of Medicine, King Khalid University Hospital, King Saud University</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Khalid University Hospital</investigator_affiliation>
    <investigator_full_name>Essam M. Manaa (MD)</investigator_full_name>
    <investigator_title>Assistant Professor &amp; Consultant</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

